GMJ Medicine
eISSN : 2626-3041
Embase
Biosis Previews
description
Volume 2, Issue 4 (2023)
GMJM 2023, 2(4): 139-143 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2023/05/14 | Accepted: 2023/11/12 | Published: 2023/12/28
Received: 2023/05/14 | Accepted: 2023/11/12 | Published: 2023/12/28
How to cite this article
Gupta M, Panizai M, Tareen M, Doreulee N. An Overview of Novel Antioxidant and Anti-Cancer Properties of Lycopene. GMJM 2023; 2 (4) :139-143
URL: http://gmedicine.de/article-2-233-en.html
URL: http://gmedicine.de/article-2-233-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Developmental Toxicology Laboratory, CSIR-Indian Institute of Toxicology Research, Lucknow, India
2- Livestock and Dairy Development Department Balochistan, Quetta, Pakistan
3- Faculty of Exact and Natural Sciences, Tbilisi State University, Tbilisi, Georgia
2- Livestock and Dairy Development Department Balochistan, Quetta, Pakistan
3- Faculty of Exact and Natural Sciences, Tbilisi State University, Tbilisi, Georgia
Abstract (883 Views)
Introduction: Lycopene, a non-provitamin A carotenoid, is the reason for redness in tomatoes and some other vegetables. Lycopene is one fat-soluble red pigment produced by plants and some microorganisms. Nowadays, the effects of lycopene on health have recently been significantly interesting. Antioxidant properties of lycopene have been received attention as an anticancer. Different studies have investigated the effects of lycopene in relation to different cancer types.
Conclusion: Lycopene significantly shows powerful anticancer activity against prostate cancer, even in progressed and aggressive conditions. This review article aims to introduce lycopene and possible mechanisms for the treatment of cancer.
Conclusion: Lycopene significantly shows powerful anticancer activity against prostate cancer, even in progressed and aggressive conditions. This review article aims to introduce lycopene and possible mechanisms for the treatment of cancer.
| | Full-Text (HTML) (39 Views)
References
1. Krubasik P, Sandmann G. A carotenogenic gene cluster from Brevibacterium linens with novel lycopene cyclase genes involved in the synthesis of aromatic carotenoids. Mol Gen Genet. 2000;263:423-32. [Link] [DOI:10.1007/s004380051186]
2. Chandrika UG, Fernando KS, Ranaweera KK. Carotenoid content and in vitro bioaccessibility of lycopene from guava (Psidium guajava) and watermelon (Citrullus lanatus) by high-performance liquid chromatography diode array detection. Int J Food Sci Nutr. 2009;60(7):558-66. [Link] [DOI:10.3109/09637480801987195]
3. Maiani G, Caston MJ, Catasta G, Toti E, Cambrodon IG, Bysted A, et al. Carotenoids: Actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol Nutr Food Res. 2009;53(2):194-218. [Link] [DOI:10.1002/mnfr.200800053]
4. Rao AV, Agarwal S. Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr. 2000;19(5):563-9. [Link] [DOI:10.1080/07315724.2000.10718953]
5. Clinton SK. Lycopene: Chemistry, biology, and implications for human health and disease. Nutr Rev. 1998;56(2 Pt 1):35-51. [Link] [DOI:10.1111/j.1753-4887.1998.tb01691.x]
6. Erdman Jr JW, Bierer TL, Gugger ET. Absorption and transport of carotenoids. Ann N Y Acad Sci. 1993;691:76-85. [Link] [DOI:10.1111/j.1749-6632.1993.tb26159.x]
7. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys. 1989;274(2):532-8. [Link] [DOI:10.1016/0003-9861(89)90467-0]
8. Miller NJ, Sampson J, Candeias LP, Bramley PM, Rice-Evans CA. Antioxidant activities of carotenes and xanthophylls. FEBS Lett. 1996;384(3):240-2. [Link] [DOI:10.1016/0014-5793(96)00323-7]
9. Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ, et al. Cis-trans lycopene isomers, carotenoids and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev. 1996;5(10):823-33. [Link]
10. Stahl W, Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than unprocessed tomato juice in humans. J Nutr. 1992;122(11):2161-6. [Link] [DOI:10.1093/jn/122.11.2161]
11. Kim GY, Kim JH, Ahn SC, Lee HJ, Moon DO, Lee CM, et al. Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-κB. Immunol. 2004;113(2):203-11. [Link] [DOI:10.1111/j.1365-2567.2004.01945.x]
12. Heber D, Lu QY. Overview of mechanisms of action of lycopene. Exp Biol Med. 2002;227(10):920-3. [Link] [DOI:10.1177/153537020222701013]
13. Velmurugan B, Bhuvaneswari V, Burra UK, Nagini S. Prevention of N-methyl-N'-nitro-N-nitrosoguanidine and saturated sodium chloride-induced gastric carcinogenesis in Wistar rats by lycopene. Eur J Cancer Preve. 2002;11(1):19-26. [Link] [DOI:10.1097/00008469-200202000-00004]
14. Palozza P, Simone R, Catalano A, Boninsegna A, Böhm V, Fröhlich K, et al. Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. J Nutr Biochem. 2010;21(1):34-46. [Link] [DOI:10.1016/j.jnutbio.2008.10.002]
15. Rao AV, Ray MR, Rao LG. Lycopene. Adv Food Nutr Res. 2006;51:99-164. [Link] [DOI:10.1016/S1043-4526(06)51002-2]
16. Rao LG, Mackinnon ES, Josse RG, Murray TM, Strauss A, Rao AV. Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women. Osteoporosis Int. 2007;18(1):109-115. [Link] [DOI:10.1007/s00198-006-0205-z]
17. Palozza P, Colangelo M, Simone R, Catalano A, Boninsegna A, Lanza P, et al. Lycopene inhibits cell growth by altering the mevalonate pathway and Ras signaling in cancer cell lines. Carcinogen. 2010;31(10):1813-21. [Link] [DOI:10.1093/carcin/bgq157]
18. Canene-Adams K, Campbell JK, Zaripheh S, Jeffery EH, Erdman JW. The tomato as a functional food. J Nutr. 2005;135(5):1226-30. [Link] [DOI:10.1093/jn/135.5.1226]
19. Shi J, Le Maguer M. Lycopene in tomatoes: Chemical and physical properties affected by food processing. Crit Rev Food Sci Nutr. 2000;40(1):1-42. [Link] [DOI:10.1080/10408690091189275]
20. Raiola A, Rigano MM, Calafiore R, Frusciante L, Barone A. Enhancing the health-promoting effects of tomato fruit for biofortified food. Mediators Inflamm. 2014:139873. [Link] [DOI:10.1155/2014/139873]
21. Krinsky NI. Antioxidant functions of carotenoids. Free Radic Biol Med. 1989;7(6):617-35. [Link] [DOI:10.1016/0891-5849(89)90143-3]
22. Frusciante L, Carli P, Ercolano MR, Pernice R, Di Matteo A, Fogliano V, et al. Antioxidant nutritional quality of tomato. Moi Nutr Food Res. 2007;51(5):609-17. [Link] [DOI:10.1002/mnfr.200600158]
23. Stahl W, Sies H. Antioxidant activity of carotenoids. Moi Aspects Med. 2003;24(26):345-51. [Link] [DOI:10.1016/S0098-2997(03)00030-X]
24. Ben-Dor A, Steiner M, Gheber L, Danilenko M, Dubi N, Linnewiel K, et al. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther. 2005;4(1):177-86. [Link] [DOI:10.1158/1535-7163.177.4.1]
25. Goo YA, Li Z, Pajkovic N, Shaffer S, Taylor G, Chen J, et al. Systematic investigation of lycopene effects in LNCaP cells by use of novel large-scale proteomic analysis software. Proteomics Clin App. 2007;1(5):513-23. [Link] [DOI:10.1002/prca.200600511]
26. Linnewiel K, Ernst H, Caris-Veyrat C, Ben-Dor A, Kampf A, Salman H, et al. Structure activity relationship of carotenoid derivatives in activation of the electrophile/ antioxidant response element transcription system. Free Radic Biol Med. 2009;47(5):659-67. [Link] [DOI:10.1016/j.freeradbiomed.2009.06.008]
27. Duthie SJ, Ma A, Ross MA, Collins AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res. 1996;56(6):1291-5. [Link]
28. Bast A, Haenen GR, van den Berg R, van den Berg H. Antioxidant effects of carotenoids. Int J Vitam Nutr Res. 1998;68(6):399-403. [Link]
29. Agarwal A, Shen H, Agarwal S, Rao AV. Lycopene content of tomato products: Its stability, bioavailability and in vivo antioxidant properties. J Med Food. 2001;4(1):9-15. [Link] [DOI:10.1089/10966200152053668]
30. Palozza P, Parrone N, Catalano A, Simone R. Tomato lycopene and inflammatory cascade: Basic interactions and clinical implications. Curr Med Chem. 2010;17(23):2547-63. [Link] [DOI:10.2174/092986710791556041]
31. Devaraj S, Mathur S, Basu A, Aung HH, Vasu VT, Meyers S, et al. A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress. J Am Coll Nutr. 2008;27:267-73. [Link] [DOI:10.1080/07315724.2008.10719699]
32. Neyestani TR, Shariatzadeh N, Gharavi A, Kalayi A, Khalaji N. Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with Type 2 diabetes mellitus: A possible role in the prevention of long-term complications. J Endocrinol Invest. 2007;30(10):833-8. [Link] [DOI:10.1007/BF03349224]
33. Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahun A, et al. Lycopene interferes with cell cycle progression and insuline-growth factor I signalling in mammary cancer cells. Nutr Cancer. 2000;36(1):101-11. [Link] [DOI:10.1207/S15327914NC3601_14]
34. Agarwal S, Rao AV. Tomato lycopene and low density lipoprotein oxidation: A human dietary intervention study. Lipids. 1998;33(10):981-4. [Link] [DOI:10.1007/s11745-998-0295-6]
35. Palozza P, Serini S, Di Nicuolo F, Calviello G. Modulation of apoptotic signalling by carotenoids in cancer cells. Arch Biochem Biophys. 2004;430(1):104-9. [Link] [DOI:10.1016/j.abb.2004.02.038]
36. Levy J, Bosin E, Feldmen B, Giat Y, Miinster A, Danilenko M, et al. Lycopene is a more potent inhibitor of human cancer cell proliferation than either a-carotene or b-carotene. Nutr Cancer. 1995;24(3):257-66. [Link] [DOI:10.1080/01635589509514415]
37. Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, et al. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene. 2001;20(26):3428-36. [Link] [DOI:10.1038/sj.onc.1204452]
38. Nahum A, Zeller L, Danilenko M, Prall OW, Watts CK, Sutherland RL, et al. Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. Eur J Nutr. 2006;45(5):275-82. [Link] [DOI:10.1007/s00394-006-0595-x]
39. Siler U, Barella L, Spitzer V, Schnorr J, Lein M, Goralczyk R, et al. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J. 2004;18(9):1019-21. [Link] [DOI:10.1096/fj.03-1116fje]
40. Ivanov NI, Cowell SP, Brown P, Rennie PS, Guns ES, Cox ME. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clin Nutr. 2007;26:252-63. [Link] [DOI:10.1016/j.clnu.2007.01.002]